F.D.A. Approves Drug for Rare Form of A.L.S.

The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness.

from NYT > Health https://ift.tt/f5YqXi9
via health&fitness